ONTOLOGY REPORT - ANNOTATIONS
| Term: | ATP |
|
| Accession: | CHEBI:15422
|
browse the term
|
| Definition: | A purine ribonucleoside 5'-triphosphate that has formula C10H16N5O13P3. |
| Synonyms: | exact_synonym: | adenosine 5'-(tetrahydrogen triphosphate) |
| | related_synonym: | ADENOSINE-5'-TRIPHOSPHATE; Adenosine triphosphate; C10H16N5O13P3; H4atp; InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1; InChIKey=ZKHQWZAMYRWXGA-KQYNXXCUSA-N; Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O |
| | alt_id: | CHEBI:10789; CHEBI:10841; CHEBI:13236; CHEBI:22249; CHEBI:2359; CHEBI:40938 |
| | xref_casrn: | 56-65-5 |
| | xref: | Beilstein:73010 "Beilstein Registry Number"; ChEMBL:114264 "ChEMBL COMPOUND"; ChemIDplus:56-65-5 "CAS Registry Number"; DrugBank:DB00171 "DrugBank"; Gmelin:34857 "Gmelin Registry Number"; KEGG COMPOUND:56-65-5 "CAS Registry Number"; KEGG COMPOUND:C00002 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D000255 |
| | xref: | PDBeChem:ATP "PDBeChem"; Patent:US3079379 "Patent" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:57299 |
|
|
ATP
|
| G |
Abca8 |
ATP-binding cassette, subfamily A (ABC1), member 8 |
|
multiple interactions |
ISO |
10 |
99,392,053 |
99,452,833 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases hydrolysis |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects binding |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases hydrolysis |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases hydrolysis |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects binding |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases hydrolysis |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects binding |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
multiple interactions |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
increases secretion |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
affects binding |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
EXP |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
multiple interactions |
EXP |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
multiple interactions |
EXP |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
multiple interactions |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Atp7a |
ATPase, Cu++ transporting, alpha polypeptide |
|
multiple interactions |
ISO |
X |
94,192,540 |
94,249,776 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
increases phosphorylation |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
multiple interactions |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
increases hydrolysis |
EXP |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases secretion |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Cabin1 |
calcineurin binding protein 1 |
|
multiple interactions |
EXP |
20 |
13,444,801 |
13,569,453 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases activity |
EXP |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
multiple interactions |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases secretion |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases abundance |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases secretion |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases export |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
affects chemical synthesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
affects chemical synthesis |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases abundance |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
|
increases activity |
ISO |
11 |
35,577,083 |
35,594,291 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
multiple interactions |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
affects response to substance |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
affects binding |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mfn2 |
mitofusin 2 |
|
decreases response to substance |
ISO |
5 |
164,951,252 |
164,980,763 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases secretion |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mt-atp6 |
mitochondrially encoded ATP synthase 6 |
|
affects abundance |
EXP |
MT |
7,919 |
8,599 |
RGD:6480464 |
CTD |
| G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
|
increases abundance |
ISO |
MT |
8,599 |
9,382 |
RGD:6480464 |
CTD |
| G |
Nadsyn1 |
NAD synthetase 1 |
|
multiple interactions |
ISO |
1 |
204,187,585 |
204,237,424 |
RGD:6480464 |
CTD |
| G |
Ncs1 |
neuronal calcium sensor 1 |
|
increases response to substance |
EXP |
3 |
10,305,202 |
10,354,149 |
RGD:6480464 |
CTD |
| G |
Ncs1 |
neuronal calcium sensor 1 |
|
multiple interactions |
EXP |
3 |
10,305,202 |
10,354,149 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
affects localization |
EXP |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
affects localization |
EXP |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
multiple interactions |
ISO |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
affects response to substance |
ISO |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
multiple interactions |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases secretion |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
P2rx1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
|
multiple interactions |
EXP |
10 |
59,889,933 |
59,904,985 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
increases activity |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
increases activity |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
multiple interactions |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
affects activity |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
ISO |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
ISO |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
multiple interactions |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
decreases response to substance |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
EXP |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
multiple interactions |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
affects activity |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
EXP |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry13 |
purinergic receptor P2Y, G-protein coupled, 13 |
|
multiple interactions |
ISO |
2 |
148,600,612 |
148,601,622 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
increases activity |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
affects activity |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
EXP |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
multiple interactions |
ISO |
X |
88,589,534 |
88,590,947 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
multiple interactions |
ISO |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
decreases activity |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
increases export |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
multiple interactions |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
decreases activity |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
multiple interactions |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
affects binding |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
multiple interactions |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
multiple interactions |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases activity |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases secretion |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
|
multiple interactions |
ISO |
1 |
77,345,194 |
77,369,417 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
multiple interactions |
ISO |
9 |
104,617,400 |
104,653,856 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
multiple interactions |
ISO |
9 |
104,617,400 |
104,653,856 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
multiple interactions |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases secretion |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases secretion |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
increases secretion |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
increases secretion |
ISO |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
multiple interactions |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc25a14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
|
decreases chemical synthesis |
ISO |
X |
135,035,550 |
135,073,837 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases stability |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects chemical synthesis |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sugt1 |
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
60,840,998 |
60,881,860 |
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
multiple interactions |
ISO |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
increases abundance |
ISO |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases hydrolysis |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
decreases activity |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
decreases activity |
EXP |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases activity |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
adenosine 5'-[gamma-thio]triphosphate
|
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
affects response to substance |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
Term paths to the root
|